Transdermal delivery of prostaglandins
Transdermal delivery of Prostaglandin E<sub>1</sub> (PGE<sub>1</sub>) would represent a significant improvement over the currently available injectable dosage forms in terms of reduced side effects and improved patient acceptance and compliance with therapy. PGE<sub>1&l...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
University of Saskatchewan
1996
|
| Online Access: | http://library.usask.ca/theses/available/etd-10212004-000842 |